Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. During the conference week, the Company's leadership team, including U.S. CEO Mark Saxton, held a series of meetings with institutional investors and healthcare industry veterans. These disc ...